4/19
07:57 am
igms
IGM Biosciences Insiders Placed Bullish Bets Worth US$992.2k [Yahoo! Finance]
Low
Report
IGM Biosciences Insiders Placed Bullish Bets Worth US$992.2k [Yahoo! Finance]
4/18
08:04 am
igms
IGM Biosciences, Inc. (NASDAQ: IGMS) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Medium
Report
IGM Biosciences, Inc. (NASDAQ: IGMS) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
4/17
08:50 am
igms
IGM Biosciences Announces Refocusing of Sanofi Collaboration [Yahoo! Finance]
High
Report
IGM Biosciences Announces Refocusing of Sanofi Collaboration [Yahoo! Finance]
4/17
08:30 am
igms
IGM Biosciences Announces Refocusing of Sanofi Collaboration
High
Report
IGM Biosciences Announces Refocusing of Sanofi Collaboration
4/10
07:00 am
igms
IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
Medium
Report
IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
3/17
12:49 pm
igms
Imvotamab Clinical Trials Bispecific Antibodies Market Growth Outlook [Yahoo! Finance]
Low
Report
Imvotamab Clinical Trials Bispecific Antibodies Market Growth Outlook [Yahoo! Finance]
3/7
07:59 pm
igms
IGM Biosciences, Inc. (IGMS) Reports Q4 Loss, Lags Revenue Estimates [Yahoo! Finance]
Medium
Report
IGM Biosciences, Inc. (IGMS) Reports Q4 Loss, Lags Revenue Estimates [Yahoo! Finance]
3/7
04:23 pm
igms
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
Medium
Report
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
3/7
04:10 pm
igms
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Medium
Report
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
2/15
02:55 am
igms
MEDIVIR AB - YEAR-END REPORT JANUARY - DECEMBER 2023 [Yahoo! Finance]
Medium
Report
MEDIVIR AB - YEAR-END REPORT JANUARY - DECEMBER 2023 [Yahoo! Finance]
2/12
03:25 pm
igms
IGM Biosciences: Imvotamab Data 2nd Half Of 2024 With Other Inflection Points [Seeking Alpha]
Neutral
Report
IGM Biosciences: Imvotamab Data 2nd Half Of 2024 With Other Inflection Points [Seeking Alpha]
2/9
07:09 am
igms
IGM Biosciences, Inc. (NASDAQ: IGMS) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating. They now have a $21.00 price target on the stock, up previously from $9.00.
Medium
Report
IGM Biosciences, Inc. (NASDAQ: IGMS) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating. They now have a $21.00 price target on the stock, up previously from $9.00.
2/1
07:00 am
igms
IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
High
Report
IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference